Anti-Cdh17 Car-T Cells
CDH17-positive Advanced Solid Tumors
920th Hospital of Joint Logistics Support Force of People's Liberation Army of ChinaCell therapyEarly Phase 1Active
C
39/ 100
Provisional rating · Methodology v0.2
Rating breakdown
- Clinical Evidence
- 24/ 100
- Competitive Position
- 95/ 100
Competitive context
1 Active assets in the CDH17-positive Advanced Solid Tumors cohort.
| Asset / Sponsor | Phase | Rating |
|---|---|---|
bhb810 BigHat Biosciences, Inc. | Phase 1/2 | CCC |
Same molecule, other indications
Anti-Cdh17 Car-T Cells is also rated in:
Are you the sponsor?
Submit your data room for a Verified Rating. The public-data rating remains visible alongside.
Contact →